Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01601574 · ClinicalTrials.gov registry record · Phase 3
Weight Loss Study for People With Type 2 Diabetes
A Phase 3 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 3
- Development phase
- 563
- Enrollment target
NCT01601574: Completed Phase 3 study, sponsored by Medical University of South Carolina.
NCT01601574 is a Phase 3 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 563 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (27% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01601574, a Phase 3 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 563 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the Weight Watchers program modified for use by people with Type 2 diabetes results in more improvements in blood glucose control relative to a control group receiving standard diabetes counseling.
Interventions
- BEHAVIORAL Weight Watchers modified program
- OTHER Standard Care group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 563 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-09 |
| Phase | Phase 3 |
What the finished NCT01601574 record still lists
NCT01601574 is an interventional study that assigns participants to a tested intervention. The registered 563 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (27% lower).
The record links to 0 conditions, and to 2 interventions - of which Weight Watchers modified program is the first listed.
NCT01601574 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01601574 about?
NCT01601574 is a clinical study titled "Weight Loss Study for People With Type 2 Diabetes". The purpose of this study is to determine whether the Weight Watchers program modified for use by people with Type 2 diabetes results in more improvements in blood glucose control relative to a control group receiving standard diabetes counseling.
What is the current status of trial NCT01601574?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 563 participants. The study started on 2012-05. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01601574?
The interventions under investigation include: Weight Watchers modified program (BEHAVIORAL), Standard Care group (OTHER).
Who is sponsoring clinical trial NCT01601574?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01601574's enrollment target sits among peer trials
563 668th of 2000 higher than 1,332 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146725 · 564 participants
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- NCT06188520 · 564 participants · Phase 1
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- NCT06628453 · 564 participants · NA
CGM for Management of Type 2 Diabetes in Pregnancy
- NCT07125326 · 564 participants · NA
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia